A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Clinical trial NCT01708161 · TERMINATED

Trial details

NCT number

NCT01708161

Sponsor

Novartis Pharmaceuticals

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2012-11-27

Primary completion

2014-12-26

Enrollment

47

View on ClinicalTrials.gov